UKs’ NHS to use genomic testing to predict heart disease risk
UKs’ NHS to use genomic testing to predict heart disease risk
A university spin-off company is to lead a pilot study within the UK’s national health service (NHS) to use genetic
A university spin-off company is to lead a pilot study within the UK’s national health service (NHS) to use genetic
A new clinical study has highlighted how whole genome sequencing is making the diagnosis of rare diseases possible. The study, reported in the journal
Research from Sidra Medicine has developed a saliva-based test, which they believe could a “a stepping stone to precision medicine.” Part of
Tamoxifen has been used to treat breast cancer for a number of years, reducing the recurrence rate to ~30%. The effectiveness of tamoxifen is not
Genetic screening has been at the forefront of the move towards precision medicine since it was first conceptualised. As the technology for
Investment in precision medicine and diagnostics continues to grow, with Konica Minolta Precision Medicine (KMPM) and
The possibilities of personalised medicine are constantly developing. The opportunities highlighted by genomic analysis and linking that data to medical
The precision medicine market is booming. Already valued at over $50 billion, its growth is expected to continue unabated, with estimates
Non-communicable diseases are responsible for more deaths than any other cause, with 71% of all deaths dying from these globally. In Africa, the rate of
The Qatar Foundation has published a pivotal report, following the first genetic association study
Special Thanks to our 2022 Sponsors & Partners
Gold Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Travel Partner
Headline Media Partner
Media Partner
Industry Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Industry Partner
Important Notice:
We are committed to providing you with a safe environment following all the health & safety guidelines set out by the local authorities. PrecisionMed Exhibition & Summit will deliver the event with strict standards of health & safety precautionary measures, including social distancing, contactless transactions, and hygiene protocols.
Organised by: Smart Planet Media Limited Exhibitions & Conferences
© PrecisionMed Exhibition & Summit 2022. All rights reserved. Registered in England and Wales. Company Number: 110730154.